In 2013, Chalan et al. reported that CD4+CD161+T cells in the joints of late-stage RA tend towards a proinflammatory IFNγ signature, that is, Th17 cell-derived Th1 or nonclassic Th1 [8]. The gene discussed is IFNG; the disease is rheumatoid arthritis.